» Articles » PMID: 36176469

Potential Lipolytic Regulators Derived from Natural Products As Effective Approaches to Treat Obesity

Overview
Specialty Endocrinology
Date 2022 Sep 30
PMID 36176469
Authors
Affiliations
Soon will be listed here.
Abstract

Epidemic obesity is contributing to increases in the prevalence of obesity-related metabolic diseases and has, therefore, become an important public health problem. Adipose tissue is a vital energy storage organ that regulates whole-body energy metabolism. Triglyceride degradation in adipocytes is called lipolysis. It is closely tied to obesity and the metabolic disorders associated with it. Various natural products such as flavonoids, alkaloids, and terpenoids regulate lipolysis and can promote weight loss or improve obesity-related metabolic conditions. It is important to identify the specific secondary metabolites that are most effective at reducing weight and the health risks associated with obesity and lipolysis regulation. The aims of this review were to identify, categorize, and clarify the modes of action of a wide diversity of plant secondary metabolites that have demonstrated prophylactic and therapeutic efficacy against obesity by regulating lipolysis. The present review explores the regulatory mechanisms of lipolysis and summarizes the effects and modes of action of various natural products on this process. We propose that the discovery and development of natural product-based lipolysis regulators could diminish the risks associated with obesity and certain metabolic conditions.

Citing Articles

Effect of onion peel extract and quercetin at an equivalent concentration in the extract on the improvement of dyslipidemia induced by high fat diet in rats.

Son M, Kim J, Lee G, Zhou Y, Jeon D, Kwon J Food Sci Biotechnol. 2025; 34(4):1045-1054.

PMID: 39974851 PMC: 11833001. DOI: 10.1007/s10068-024-01741-7.


First transcriptome analysis of the venom glands of the scorpion (Scorpions: Buthidae) with focus on venom lipolysis activating peptides.

Salabi F, Jafari H, Mahdavinia M, Azadnasab R, Shariati S, Baghal M Front Pharmacol. 2024; 15:1464648.

PMID: 39605918 PMC: 11598519. DOI: 10.3389/fphar.2024.1464648.


Royal Jelly Exerts a Potent Anti-Obesity Effect in Rats by Activating Lipolysis and Suppressing Adipogenesis.

Felemban A, Alshammari G, Yagoub A, Saleh A, Yahya M Nutrients. 2024; 16(18).

PMID: 39339774 PMC: 11435164. DOI: 10.3390/nu16183174.


Anti‑obesity and immunostimulatory activity of in mouse preadipocytes 3T3‑L1 cells and mouse macrophage RAW264.7 cells.

Choi J, Park G, Choi H, Lee J, Kwon H, Choi M Exp Ther Med. 2024; 28(2):315.

PMID: 38911047 PMC: 11190883. DOI: 10.3892/etm.2024.12604.


Plant Secondary Compounds Promote White Adipose Tissue Browning via Modulation of the Gut Microbiota in Small Mammals.

Ren S, Zhang L, Tang X, Fan C, Zhao Y, Cheng Q Int J Mol Sci. 2023; 24(24).

PMID: 38139249 PMC: 10743627. DOI: 10.3390/ijms242417420.


References
1.
Turovsky E, Varlamova E, Turovskaya M . Activation of Cx43 Hemichannels Induces the Generation of Ca Oscillations in White Adipocytes and Stimulates Lipolysis. Int J Mol Sci. 2021; 22(15). PMC: 8347185. DOI: 10.3390/ijms22158095. View

2.
Li L, Zhang T, Yang L, Zhang L, Wang L, Liu B . Inhibition of lipolysis by ilexgenin A via AMPK activation contributes to the prevention of hepatic insulin resistance. Eur J Pharmacol. 2017; 813:84-93. DOI: 10.1016/j.ejphar.2017.07.038. View

3.
Carrasco-Pozo C, Cires M, Gotteland M . Quercetin and Epigallocatechin Gallate in the Prevention and Treatment of Obesity: From Molecular to Clinical Studies. J Med Food. 2019; 22(8):753-770. DOI: 10.1089/jmf.2018.0193. View

4.
Lee M, Kim C, Kim Y . Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice. Ann Nutr Metab. 2009; 54(2):151-7. DOI: 10.1159/000214834. View

5.
Roden M, Stingl H, Chandramouli V, Schumann W, Hofer A, Landau B . Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes. 2000; 49(5):701-7. DOI: 10.2337/diabetes.49.5.701. View